Elbasvir is a direct-acting antiviral agent and NS5A inhibitor specifically indicated for the treatment of chronic hepatitis C infections. This category features high-quality reference standards of the… Read more
Elbasvir is a direct-acting antiviral agent and NS5A inhibitor specifically indicated for the treatment of chronic hepatitis C infections. This category features high-quality reference standards of the parent drug, alongside its related compounds, including stable isotope labelled analogues like Elbasvir-d6. Pharmaceutical laboratories and research facilities rely on these compounds for critical analytical tasks, including the development and validation of analytical methods for impurity profiling and quantitative bioanalysis. By utilizing these certified reference materials, researchers can accurately perform quality control assays and metabolite identification, ensuring the precision of mass spectrometry workflows when monitoring drug substance consistency. Whether conducting routine stability testing or investigating degradation pathways, these standards are essential for maintaining the rigor and reproducibility required in pharmaceutical development and regulatory compliance for this NS5A inhibitor.